Skip to content
Home/Companies/Consumer Health/DermaPharm
DermaPharm

DermaPharm

Consumer Health·Denmark·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns DermaPharm?

DermaPharm is currently owned by ARCHIMED through MED III (2021 vintage), since 2025.

Hand-verified · updated 2026-04-21

ARCHIMED
Investor
ARCHIMED
MED III · 2021 · Buyout

Key facts

HQDenmark
SectorConsumer Health
Websitedermapharm.dk

More from MED III

Other portfolio companies in the same fund.

BioVendor Group
Active
MedTechCzech Republic· 2025
Natus Sensory
Natus Sensory
Active
MedTechUS· 2022
PlasmidFactory
PlasmidFactory
Active
BiotechGermany· 2022
Title21 Health Solutions
Title21 Health Solutions
Active
HealthTechUS· 2022
Aliri
Aliri
Active
PharmaUS· 2021
Cardioline
Cardioline
Active
MedTechItaly· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
agilon health
agilon health
Active
CD&RUS
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Track DermaPharm

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy DermaPharm?

1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on DermaPharm.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue